Larché M, Hoyne G, Lake R, Lamb J R
Department of Immunology, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.
Int Arch Allergy Immunol. 1994 Jul;104(3):211-5. doi: 10.1159/000236667.
T lymphocytes recognise antigen in the form of short peptides complexed with the class I and II products of the Major Histocompatibility Complex (MHC). Cellular activation follows T cell recognition of peptide-MHC complexes at immunogenic cell surface concentrations together with the participation of the appropriate costimulatory signals. Interaction of TCRs and peptide-MHC complexes under inappropriate conditions may result in antigen-specific non-responsiveness, commonly referred to as anergy. Here we review some recent model systems which have been employed to study the phenomenon of anergy and the use of peptides to induce antigen-specific non-responsiveness both in vitro and in vivo.
T淋巴细胞以与主要组织相容性复合体(MHC)的I类和II类产物复合的短肽形式识别抗原。细胞活化是在免疫原性细胞表面浓度下T细胞识别肽-MHC复合体以及适当共刺激信号参与之后发生的。在不适当条件下TCR与肽-MHC复合体的相互作用可能导致抗原特异性无反应性,通常称为无反应性。在这里,我们综述了一些最近用于研究无反应性现象以及在体外和体内使用肽诱导抗原特异性无反应性的模型系统。